Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	retinyl-palmitate esterase activity	PNPLA4 CES1 CES2	6.51e-05	9	187	3	GO:0050253
GeneOntologyMolecularFunction	acetyl-CoA carboxylase activity	ACACA ACACB	8.72e-05	2	187	2	GO:0003989
GeneOntologyMolecularFunction	methylumbelliferyl-acetate deacetylase activity	CES1 CES2	2.60e-04	3	187	2	GO:0047374
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	DDR1 NTRK1 TYRO3 ROS1 LTK	3.58e-04	65	187	5	GO:0004714
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CDH26 PCDHGB3 PCDHB4 PCDHAC1 PTPN23 FAT2 PCDH11X PCDH15 DCHS1 CDH16	9.14e-06	187	189	10	GO:0007156
Domain	Cadherin	CDH26 PCDHGB3 PCDHB4 PCDHAC1 FREM3 FAT2 PCDH11X PCDH15 DCHS1 CDH16	3.53e-07	118	190	10	IPR002126
Domain	Cadherin_CS	CDH26 PCDHGB3 PCDHB4 PCDHAC1 FAT2 PCDH11X PCDH15 DCHS1 CDH16	1.72e-06	109	190	9	IPR020894
Domain	CADHERIN_1	CDH26 PCDHGB3 PCDHB4 PCDHAC1 FAT2 PCDH11X PCDH15 DCHS1 CDH16	2.32e-06	113	190	9	PS00232
Domain	Cadherin	CDH26 PCDHGB3 PCDHB4 PCDHAC1 FAT2 PCDH11X PCDH15 DCHS1 CDH16	2.32e-06	113	190	9	PF00028
Domain	CADHERIN_2	CDH26 PCDHGB3 PCDHB4 PCDHAC1 FAT2 PCDH11X PCDH15 DCHS1 CDH16	2.50e-06	114	190	9	PS50268
Domain	-	CDH26 PCDHGB3 PCDHB4 PCDHAC1 FAT2 PCDH11X PCDH15 DCHS1 CDH16	2.50e-06	114	190	9	2.60.40.60
Domain	CA	CDH26 PCDHGB3 PCDHB4 PCDHAC1 FAT2 PCDH11X PCDH15 DCHS1 CDH16	2.68e-06	115	190	9	SM00112
Domain	Cadherin-like	CDH26 PCDHGB3 PCDHB4 PCDHAC1 FAT2 PCDH11X PCDH15 DCHS1 CDH16	2.89e-06	116	190	9	IPR015919
Domain	Tyr_kinase_rcpt_2_CS	DDR1 NTRK1 ROS1 LTK	3.24e-06	11	190	4	IPR002011
Domain	RECEPTOR_TYR_KIN_II	DDR1 NTRK1 ROS1 LTK	4.82e-06	12	190	4	PS00239
Domain	ACC_central	ACACA ACACB	1.03e-04	2	190	2	PF08326
Domain	AcCoA_COase_cen	ACACA ACACB	1.03e-04	2	190	2	IPR013537
Domain	NHL_repeat	TRIM2 LRP1B TRIM3	1.18e-04	10	190	3	IPR001258
Domain	NHL	TRIM2 LRP1B TRIM3	1.18e-04	10	190	3	PF01436
Domain	Tyr_kinase_cat_dom	DDR1 NTRK1 TYRO3 MAP3K11 ROS1 LTK	2.78e-04	88	190	6	IPR020635
Domain	TyrKc	DDR1 NTRK1 TYRO3 MAP3K11 ROS1 LTK	2.78e-04	88	190	6	SM00219
Domain	TRAM1	TRAM1L1 TRAM1	3.07e-04	3	190	2	PF08390
Domain	-	RASA4 RASA4B	3.07e-04	3	190	2	4.10.1130.10
Domain	Translocation_assoc_membrane	TRAM1L1 TRAM1	3.07e-04	3	190	2	IPR016447
Domain	TRAM1	TRAM1L1 TRAM1	3.07e-04	3	190	2	IPR013599
Domain	Carboxyl_trans	ACACA ACACB	6.09e-04	4	190	2	PF01039
Domain	COA_CT_CTER	ACACA ACACB	6.09e-04	4	190	2	PS50989
Domain	COA_CT_NTER	ACACA ACACB	6.09e-04	4	190	2	PS50980
Domain	COA_CT_N	ACACA ACACB	6.09e-04	4	190	2	IPR011762
Domain	COA_CT_C	ACACA ACACB	6.09e-04	4	190	2	IPR011763
Domain	Carboxyl_trans	ACACA ACACB	6.09e-04	4	190	2	IPR000022
Domain	-	TRIM2 LRP1B TRIM3 ROS1	6.46e-04	39	190	4	2.120.10.30
Domain	Biotin_BS	ACACA ACACB	1.01e-03	5	190	2	IPR001882
Domain	VWA_N	CACHD1 CACNA2D3	1.01e-03	5	190	2	IPR013608
Domain	VWA_N	CACHD1 CACNA2D3	1.01e-03	5	190	2	PF08399
Domain	Biotin_COase_C	ACACA ACACB	1.01e-03	5	190	2	IPR005482
Domain	BC	ACACA ACACB	1.01e-03	5	190	2	PS50979
Domain	PLPL	PNPLA4 PNPLA5	1.01e-03	5	190	2	IPR033562
Domain	Biotin_carb_C	ACACA ACACB	1.01e-03	5	190	2	SM00878
Domain	Biotin_carb_C	ACACA ACACB	1.01e-03	5	190	2	PF02785
Domain	Biotin_carboxylation_dom	ACACA ACACB	1.01e-03	5	190	2	IPR011764
Domain	CPSASE_1	ACACA ACACB	1.01e-03	5	190	2	PS00866
Domain	BIOTIN	ACACA ACACB	1.01e-03	5	190	2	PS00188
Domain	6-blade_b-propeller_TolB-like	TRIM2 LRP1B TRIM3 ROS1	1.21e-03	46	190	4	IPR011042
Domain	-	UBR5 SERGEF HERC6	1.38e-03	22	190	3	2.130.10.30
Domain	Rudment_hybrid_motif	ACACA ACACB	1.50e-03	6	190	2	IPR011054
Domain	CPSASE_2	ACACA ACACB	1.50e-03	6	190	2	PS00867
Domain	RCC1/BLIP-II	UBR5 SERGEF HERC6	1.58e-03	23	190	3	IPR009091
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	SF3B4 EMC1 CARMIL2 HDAC4 ACACA DOCK11 PLEKHG2 ECT2 RGS12 EPN2 STK4 C2CD3 PIK3C2B SVIL RNF10 TMEM102 USP54 SSH2 EPB41L2	3.55e-07	861	192	19	36931259
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	EXOSC10 PDE3A ACACB PNPLA4 HTRA2 NEB OGDH FAT2 SNX25 VPS35	7.97e-07	234	192	10	36243803
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MIER2 HAUS6 PTPN23 WDFY4 ABCA8 EPN2 FAT2 NPHP3 CPEB4 SSH2 GRIN3A PRORP PDZRN3	4.08e-06	493	192	13	15368895
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	CDH26 PCDHGB3 PCDHB4 PCDHAC1 FAT2 PCDH11X	4.48e-06	77	192	6	10835267
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	IPO5 MRE11 HAUS6 SF3B4 ACACA HTRA2 UNC13D SPG11 ZNF236 EMSY CRK BAP1 XYLT2 FBXL18 TRMT2A MOGS UBR5 VPS35 NFRKB EEF1AKMT1 SSH2 GCN1	4.71e-06	1327	192	22	32694731
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ACACA MED14 AKNA LAMC3 ZNF236 ITGB4 BAP1 ZNF503 C2CD3 PER2 CLCN7 PIK3C2B KCNG1 CSPG4 MAP3K11 DISP2 LTK MAPKBP1 GCN1	1.32e-05	1105	192	19	35748872
Pubmed	Coordinately Co-opted Multiple Transposable Elements Constitute an Enhancer for wnt5a Expression in the Mammalian Secondary Palate.	ACTR8 CHDH CACNA2D3	1.36e-05	9	192	3	27741242
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	ACACA ACACB DTNA PARD6G CACHD1 EPN2 CYFIP1 LLGL1 PIK3C2B SNTB1 EPB41L2	2.48e-05	421	192	11	36976175
Pubmed	Interleukin-6 alters the cellular responsiveness to clopidogrel, irinotecan, and oseltamivir by suppressing the expression of carboxylesterases HCE1 and HCE2.	CES1 CES2	3.03e-05	2	192	2	17537833
Pubmed	Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver.	CES1 CES2	3.03e-05	2	192	2	19487248
Pubmed	Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin.	CES1 CES2	3.03e-05	2	192	2	18983829
Pubmed	v-Crk modulation of growth factor-induced PC12 cell differentiation involves the Src homology 2 domain of v-Crk and sustained activation of the Ras/mitogen-activated protein kinase pathway.	NTRK1 CRK	3.03e-05	2	192	2	7657647
Pubmed	CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway.	RASA4 RASA4B	3.03e-05	2	192	2	11448776
Pubmed	Genetic inhibition of hepatic acetyl-CoA carboxylase activity increases liver fat and alters global protein acetylation.	ACACA ACACB	3.03e-05	2	192	2	24944901
Pubmed	The CD2 isoform of protocadherin-15 is an essential component of the tip-link complex in mature auditory hair cells.	PCDH15 MYO15A	3.03e-05	2	192	2	24940003
Pubmed	Structural organization and characterization of the regulatory element of the human carboxylesterase (CES1A1 and CES1A2) genes.	CES1 CES2	3.03e-05	2	192	2	18305377
Pubmed	Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription.	ACACA ACACB	3.03e-05	2	192	2	20139635
Pubmed	Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells.	ACACA ACACB	3.03e-05	2	192	2	28081256
Pubmed	Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle.	DTNA SYNC	3.03e-05	2	192	2	11053421
Pubmed	Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.	ACACA ACACB	3.03e-05	2	192	2	26976583
Pubmed	DelGEF, an RCC1-related protein encoded by a gene on chromosome 11p14 critical for two forms of hereditary deafness.	SERGEF LGALS13	3.03e-05	2	192	2	10571079
Pubmed	A novel type of myosin encoded by the mouse deafness gene shaker-2.	LLGL1 MYO15A	3.03e-05	2	192	2	9703981
Pubmed	Predominant contributions of carboxylesterase 1 and 2 in hydrolysis of anordrin in humans.	CES1 CES2	3.03e-05	2	192	2	28532270
Pubmed	The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2.	HTRA2 CSPG4	3.03e-05	2	192	2	26340347
Pubmed	Carbon monoxide protects the kidney through the central circadian clock and CD39.	PER2 ENTPD1	3.03e-05	2	192	2	29463714
Pubmed	Different inhibitory effects in rat and human carboxylesterases.	CES1 CES2	3.03e-05	2	192	2	19225040
Pubmed	AMPK-dependent inhibitory phosphorylation of ACC is not essential for maintaining myocardial fatty acid oxidation.	ACACA ACACB	3.03e-05	2	192	2	25001074
Pubmed	Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin.	CES1 CES2	3.03e-05	2	192	2	20649590
Pubmed	p63 regulates an adhesion programme and cell survival in epithelial cells.	ITGB4 TP63	3.03e-05	2	192	2	16715076
Pubmed	The subcellular localization of acetyl-CoA carboxylase 2.	ACACA ACACB	3.03e-05	2	192	2	10677481
Pubmed	Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways.	NTRK1 CRK	3.03e-05	2	192	2	7509449
Pubmed	Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2.	ACACA ACACB	3.03e-05	2	192	2	24338821
Pubmed	Heme-binding characteristics of the isolated PAS-A domain of mouse Per2, a transcriptional regulatory factor associated with circadian rhythms.	PER2 NPAS2	3.03e-05	2	192	2	18479150
Pubmed	De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.	ACACA ACACB	3.03e-05	2	192	2	25282359
Pubmed	Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab.	ACACA ACACB	3.03e-05	2	192	2	27693630
Pubmed	Carboxylesterase in the liver and small intestine of experimental animals and human.	CES1 CES2	3.03e-05	2	192	2	17764701
Pubmed	Effects of PKB/Akt inhibitors on insulin-stimulated lipogenesis and phosphorylation state of lipogenic enzymes in white adipose tissue.	ACACA ACACB	3.03e-05	2	192	2	32215608
Pubmed	Activity and structure of human acetyl-CoA carboxylase targeted by a specific inhibitor.	ACACA ACACB	3.03e-05	2	192	2	29772612
Pubmed	Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene.	CES1 CES2	3.03e-05	2	192	2	15475733
Pubmed	Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin.	ACACA ACACB	3.03e-05	2	192	2	29976587
Pubmed	Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.	CES1 CES2	3.03e-05	2	192	2	24212379
Pubmed	Structure and regulation of acetyl-CoA carboxylase genes of metazoa.	ACACA ACACB	3.03e-05	2	192	2	15749055
Pubmed	Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma.	BAP1 MBD4	3.03e-05	2	192	2	11309305
Pubmed	Age-Dependent Human Hepatic Carboxylesterase 1 (CES1) and Carboxylesterase 2 (CES2) Postnatal Ontogeny.	CES1 CES2	3.03e-05	2	192	2	26825642
Pubmed	Reciprocal regulation of haem biosynthesis and the circadian clock in mammals.	PER2 NPAS2	3.03e-05	2	192	2	15269772
Pubmed	Pharmacogenomic assessment of carboxylesterases 1 and 2.	CES1 CES2	3.03e-05	2	192	2	15475243
Pubmed	Archvillin anchors in the Z-line of skeletal muscle via the nebulin C-terminus.	NEB SVIL	3.03e-05	2	192	2	18639526
Pubmed	AMPK signaling to acetyl-CoA carboxylase is required for fasting- and cold-induced appetite but not thermogenesis.	ACACA ACACB	3.03e-05	2	192	2	29433631
Pubmed	Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin.	ACACA ACACB	3.03e-05	2	192	2	36076520
Pubmed	Involvement of Npas2 and Per2 modifications in zinc-induced acute diurnal toxicity in mice.	PER2 NPAS2	3.03e-05	2	192	2	36450499
Pubmed	Sex Hormone-Binding Globulin Expression Correlates With Acetyl-Coenzyme A Carboxylase and Triglyceride Content in Human Liver.	ACACA SHBG	3.03e-05	2	192	2	30496542
Pubmed	An essential function for the calcium-promoted Ras inactivator in Fcgamma receptor-mediated phagocytosis.	RASA4 RASA4B	3.03e-05	2	192	2	16041389
Pubmed	Examination of the carboxylesterase phenotype in human liver.	CES1 CES2	3.03e-05	2	192	2	22525521
Pubmed	Inhibition of hepatic lipogenesis enhances liver tumorigenesis by increasing antioxidant defence and promoting cell survival.	ACACA ACACB	3.03e-05	2	192	2	28290443
Pubmed	Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.	ACACA ACACB	3.03e-05	2	192	2	30244972
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	IPO5 MRE11 ACACA DOCK11 MED14 ECT2 HINFP THOP1 ENTPD1 TNS1	3.74e-05	363	192	10	14691545
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	IPO5 MRE11 EMC1 DTNA PTPN23 SCAMP3 CRK EPN2 CLCN7 GCN1 EPB41L2	4.45e-05	449	192	11	31732153
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	DDR1 TRIM2 NTRK1 TYRO3 FBXL18 KCNG1 NFRKB RNF10 ASB2 HERC6	4.59e-05	372	192	10	22939624
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	IPO5 SF3B4 EMC1 ACACA BMP2K PTPN23 OGDH NCCRP1 BLVRA ZBP1 THOP1 ARSB MOGS TRAM1 CSPG4 VPS35 CPEB4 HINT2 PDZRN3 EPB41L2 TPBG	5.75e-05	1451	192	21	30550785
Pubmed	Identification of a proximal progenitor population from murine fetal lungs with clonogenic and multilineage differentiation potential.	ITGB4 TP63 FOXJ1	7.18e-05	15	192	3	25358791
Pubmed	Novel protein interactions with endoglin and activin receptor-like kinase 1: potential role in vascular networks.	RASL12 EPS8L1 DUSP26 RASA4 RASA4B TSSK4	7.44e-05	126	192	6	24319055
Pubmed	Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.	IPO5 PDE3A ACACA DOCK11 PEG10 STK4 CYFIP1 UBR5 GCN1 EPB41L2	8.21e-05	399	192	10	37536630
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGB3 PCDHB4 PCDHAC1 FAT2 PCDH11X	8.37e-05	80	192	5	10716726
Pubmed	ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer.	NTRK1 ROS1	9.06e-05	3	192	2	29370427
Pubmed	AMPK activation by SC4 inhibits noradrenaline-induced lipolysis and insulin-stimulated lipogenesis in white adipose tissue.	ACACA ACACB	9.06e-05	3	192	2	34668531
Pubmed	Sleep loss reduces the DNA-binding of BMAL1, CLOCK, and NPAS2 to specific clock genes in the mouse cerebral cortex.	PER2 NPAS2	9.06e-05	3	192	2	22039518
Pubmed	Evi27 encodes a novel membrane protein with homology to the IL17 receptor.	ACTR8 CHDH	9.06e-05	3	192	2	10815801
Pubmed	AMPK-ACC signaling modulates platelet phospholipids and potentiates thrombus formation.	ACACA ACACB	9.06e-05	3	192	2	30018077
Pubmed	DelGEF, a homologue of the Ran guanine nucleotide exchange factor RanGEF, binds to the exocyst component Sec5 and modulates secretion.	SERGEF LGALS13	9.06e-05	3	192	2	12459492
Pubmed	CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane.	RASA4 RASA4B	9.06e-05	3	192	2	25637021
Pubmed	Distinct signaling and transcriptional pathways regulate peri-weaning development and cold-induced recruitment of beige adipocytes.	NTRK1 BCL6	9.06e-05	3	192	2	32139607
Pubmed	ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion.	FAT2 TP63	9.06e-05	3	192	2	27081041
Pubmed	Human carboxylesterases: an update on CES1, CES2 and CES3.	CES1 CES2	9.06e-05	3	192	2	19508181
Pubmed	CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock.	PER2 NPAS2	9.06e-05	3	192	2	17417633
Pubmed	Acetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels.	ACACA ACACB	9.06e-05	3	192	2	19846279
Pubmed	Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.	ACACA ACACB	9.06e-05	3	192	2	18031993
Pubmed	Immunoexpression of BAP1, ROS1, and ALK in Spitzoid Melanocytic Tumors.	BAP1 ROS1	9.06e-05	3	192	2	29623743
Pubmed	Human carboxylesterases in term placentae: enzymatic characterization, molecular cloning and evidence for the existence of multiple forms.	CES1 CES2	9.06e-05	3	192	2	10452915
Pubmed	Induced polymerization of mammalian acetyl-CoA carboxylase by MIG12 provides a tertiary level of regulation of fatty acid synthesis.	ACACA ACACB	9.06e-05	3	192	2	20457939
Pubmed	Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism.	ACACA ACACB	9.06e-05	3	192	2	36417534
Pubmed	Identification of Pathogenic Genes of Nonsyndromic Hearing Loss in Uyghur Families Using Massively Parallel DNA Sequencing Technique.	PCDH15 MYO15A	9.06e-05	3	192	2	29692870
Pubmed	Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression.	PER2 NPAS2	9.06e-05	3	192	2	17457720
Pubmed	Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate.	ACACA ACACB	9.06e-05	3	192	2	18455495
Pubmed	Pseudosarcomatous myofibroblastic proliferations of the genitourinary tract are genetically different from nodular fasciitis and lack USP6, ROS1 and ETV6 gene rearrangements.	USP6 ROS1	9.06e-05	3	192	2	29617048
Pubmed	NPAS2 Compensates for Loss of CLOCK in Peripheral Circadian Oscillators.	PER2 NPAS2	9.06e-05	3	192	2	26895328
Pubmed	Peripheral circadian oscillators require CLOCK.	PER2 NPAS2	9.06e-05	3	192	2	17637349
Pubmed	Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity.	CES1 CES2	9.06e-05	3	192	2	20195289
Pubmed	Alternative splicing of dystrobrevin regulates the stoichiometry of syntrophin binding to the dystrophin protein complex.	DTNA SNTB1	9.06e-05	3	192	2	11069112
Pubmed	Genome-wide analysis reveals that altered methylation in specific CpG loci is associated with childhood obesity.	HDAC4 CES1	9.06e-05	3	192	2	29797594
Pubmed	Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.	ACACA ACACB	9.06e-05	3	192	2	28877461
Pubmed	A comparative study of human GS2, its paralogues, and its rat orthologue.	PNPLA4 PNPLA5	9.06e-05	3	192	2	17603008
Pubmed	Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas.	ACACA ACACB	9.06e-05	3	192	2	17521700
Pubmed	Non-clustered protocadherin.	PCDH11X PCDH15	9.06e-05	3	192	2	21173574
Pubmed	Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis.	ACACA ACACB	9.06e-05	3	192	2	31990961
Pubmed	The Na+/Glucose Cotransporter Inhibitor Canagliflozin Activates AMPK by Inhibiting Mitochondrial Function and Increasing Cellular AMP Levels.	ACACA ACACB	9.06e-05	3	192	2	27381369
Pubmed	Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice.	ACACA ACACB	9.06e-05	3	192	2	17210641
Pubmed	Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation.	ACACA ACACB	9.06e-05	3	192	2	28768177
Pubmed	The protein tyrosine kinase family of the human genome.	DDR1 NTRK1 TYRO3 ROS1 LTK	9.97e-05	83	192	5	11114734
Pubmed	Chronic otitis media is initiated by a bulla cavitation defect in the FBXO11 mouse model.	BCL6 SMAD5 FOXJ1	1.76e-04	20	192	3	30898767
Pubmed	Control of stereocilia length during development of hair bundles.	PCDH15 MYO15A	1.81e-04	4	192	2	37011103
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	DDR1 NTRK1 TYRO3 ROS1 LTK	8.87e-06	40	128	5	321
GeneFamily	Cadherin related	FAT2 PCDH15 DCHS1	2.19e-04	17	128	3	24
GeneFamily	Carboxylesterases	CES1 CES2	4.90e-04	5	128	2	461
GeneFamily	TLC domain containing	TRAM1L1 TRAM1	2.16e-03	10	128	2	1374
GeneFamily	Patatin like phospholipase domain containing	PNPLA4 PNPLA5	2.16e-03	10	128	2	466
GeneFamily	Pleckstrin homology domain containing\|SH2 domain containing\|C2 and RasGAP domain containing	RASA4 RASA4B	2.16e-03	10	128	2	830
GeneFamily	DNA glycosylases	NEIL1 MBD4	2.62e-03	11	128	2	1024
GeneFamily	Laminin subunits	LAMB4 LAMC3	3.13e-03	12	128	2	626
Coexpression	GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN	BMP2K BCL6 HSF5 PIK3C2B KCNG1 SUPT6H SEMA4A EPB41L2 TREML2	1.51e-05	198	190	9	M9234
Coexpression	GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN	TRIM2 PTPN23 UNC13D PIGV PRAM1 UBR5 VPS35 RNF10 SEMA4A	1.57e-05	199	190	9	M3560
Coexpression	GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN	CCNO SPG11 ZNF236 HSF5 CLCN7 UBR5 CD180 HERC6 BANK1	1.64e-05	200	190	9	M7303
CoexpressionAtlas	Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1	DDR1 BMP2K BCL6 WDFY4 RGS12 SERPINB10 RASA4 ENTPD1 MYO1F AVPI1 ASB2 CD180 TNS1 BANK1	8.34e-06	382	188	14	GSM538248_500
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A DTNA RASL12 LRP1B FNDC1 ENTPD1 FAM124A ASB2 PDZRN3 CDH16 CACNA2D3	9.43e-10	196	191	11	9830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2\|TCGA-Kidney / Sample_Type by Project: Shred V9	ITGA11 PDE3A PLEKHG2 HEPH FNDC1 CSPG4 ENTPD1 DCHS1 DAAM2	1.17e-07	186	191	9	1e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CYFIP1 TRAM1 VPS35 ENTPD1 SSH2 GCN1 BANK1 EPB41L2	1.68e-07	194	191	9	50c5fc349533281a426bc7227a8ea9eca8d11985
ToppCell	facs-Brain_Myeloid-Cortex-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CYFIP1 TRAM1 VPS35 ENTPD1 SSH2 GCN1 BANK1 EPB41L2	1.68e-07	194	191	9	1662b110f84584e75150df0ac970e7df82f26e7e
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CYFIP1 TRAM1 VPS35 ENTPD1 SSH2 GCN1 BANK1 EPB41L2	1.68e-07	194	191	9	b31d6361fa939a92a4a3dc63c209ecd3eb514e6a
ToppCell	Sepsis-Int-URO-Lymphocyte-B-Plasmablast\|Int-URO / Disease, condition lineage and cell class	CDH26 ACY3 EPN2 PIK3C2B TP63 DPEP3 RASA4B LTK ASB2	1.83e-07	196	191	9	e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DTNA RASL12 LRP1B DUSP26 FNDC1 DAAM2 ASB2 PDZRN3 PTTG2	1.99e-07	198	191	9	cbb63b255bdc92a557c5db1f08f7766ed9346607
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE3A ZCCHC12 ZFP57 SVIL PCDH11X SNTB1 EPB41L2 TPBG	3.33e-07	153	191	8	9c6fce56300ba5053efda59a438d63a808c497c0
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	PDE3A DTNA RASL12 SVIL ASB2 TNS1 PDZRN3 CACNA2D3	8.46e-07	173	191	8	cb6389536195443633adb06e5f1b7483530773d1
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-3\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFP57 HINFP TYRO3 FAT2 TP63 PCDH11X ROS1 TPBG	8.84e-07	174	191	8	76310c0af1d7df6a4de3816838b2ac2892f68746
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A PARD6G LAMC3 RASL12 CSPG4 DAAM2 TNS1 EPB41L2	1.05e-06	178	191	8	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A DTNA SLC6A17 RASL12 CSPG4 DAAM2 ASB2 SNTB1	1.09e-06	179	191	8	8da6863edc756540bb097cc7221c1408640d9bb4
ToppCell	facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE3A DTNA SLC6A17 RASL12 CSPG4 DAAM2 ASB2 SNTB1	1.09e-06	179	191	8	f39c13c99a07d009cc677e363ffe089089c64916
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	ITGA11 PDE3A DTNA RASL12 SVIL ASB2 TNS1 PDZRN3	1.14e-06	180	191	8	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DDR1 PDE3A ZCCHC12 PEG10 LAMC3 RGS12 KCNG1 GRIN3A	1.14e-06	180	191	8	b6efdb4d319ef6f87f559acd974e5a71b06a2322
ToppCell	droplet-Bladder-BLADDER-1m-Hematologic-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAUS6 DOCK11 EID2B AKNA UNC13D NCCRP1 RASA4 ASB2	1.40e-06	185	191	8	969248b63d4ce335f223528de756bcddffadbd77
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ITGA11 CES1 DTNA HEPH DUSP26 FNDC1 DCHS1 ASB2	1.58e-06	188	191	8	c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 RASL12 FNDC1 CSPG4 DAAM2 EPB41L2	1.71e-06	190	191	8	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 RASL12 PLEKHG2 CSPG4 DAAM2 EPB41L2	1.78e-06	191	191	8	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 RASL12 PLEKHG2 CSPG4 DAAM2 EPB41L2	1.78e-06	191	191	8	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	facs-Skin\|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDR1 BCL6 ITGB4 FAT2 SERPINB10 TP63 CSPG4 AVPI1	1.78e-06	191	191	8	ae524103331fa53fa82888dbb567fc36abcee7e0
ToppCell	facs-Brain_Myeloid-Cortex-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMP2K CYFIP1 TRAM1 ENTPD1 SSH2 GCN1 BANK1 EPB41L2	2.00e-06	194	191	8	2224c7c943cfd5c1a329dfcf19d6e5ef8c49d85d
ToppCell	mLN-B_cell-B_cell_cycling\|mLN / Region, Cell class and subclass	PEG10 CHDH ACY3 BCL6 NEB ECT2 TP63 ASB2	2.24e-06	197	191	8	806dddcca85c82bd642008d930c8db16b613d88e
ToppCell	mLN-(2)_B_cell-(24)_B_cell_cycling\|mLN / shred on region, Cell_type, and subtype	PEG10 CHDH ACY3 BCL6 NEB ECT2 TP63 ASB2	2.24e-06	197	191	8	70fff2d6723f259e18e7a21d22dc46d71f0759ce
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 BCL6 ABCA8 CSPG4 DAAM2 EPB41L2	2.33e-06	198	191	8	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE3A DTNA LRP1B FNDC1 ASB2 TNS1 PDZRN3 CACNA2D3	2.33e-06	198	191	8	22e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	SYNC RASL12 LRP1B DUSP26 FNDC1 SVIL ENTPD1 ASB2	2.41e-06	199	191	8	a207b4891881149d4c50721310690fd794157723
ToppCell	control-cDC\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DTNA WDFY4 ZNF503 CYFIP1 SEMA4A ASB2 EPB41L2 CACNA2D3	2.51e-06	200	191	8	4a6d17a4225be38537d3dd8a39512051f597f4e0
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte\|Control_saline / Treatment groups by lineage, cell group, cell type	PDE3A DOCK11 LAMC3 RASL12 TYRO3 CSPG4 DAAM2 EPB41L2	2.51e-06	200	191	8	cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_4\|356C / Donor, Lineage, Cell class and subclass (all cells)	NTRK1 NPDC1 UTS2 TP63 ENTPD1 PCDH11X RASA4B	4.47e-06	153	191	7	cda759ab83a271974651fe4faa21ed4f7ecbb3ae
ToppCell	Int-URO-Lymphocyte-B-Plasmablast\|Int-URO / Disease, Lineage and Cell Type	CDH26 ACY3 TP63 DPEP3 RASA4B LTK ASB2	5.76e-06	159	191	7	f6ad73b6a3681471efbd4fafd9eb631764c53500
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ZCCHC12 DOCK11 PCDH11X DCHS1 DAAM2 GRIN3A CREB3L2	6.25e-06	161	191	7	bf70be1de418615b5442ec684552551edaf1f072
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A PLEKHG2 HEPH DAAM2 GRIN3A EPB41L2	6.25e-06	161	191	7	1b805f77790aeb8a71b08bfac2fe2eed7343258f
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A DUOX2 GRIA4 PLEKHG2 CSPG4 DAAM2 ASB2	6.51e-06	162	191	7	5d902bb31e691aea9749617cc88303c2448f24b8
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A DUOX2 GRIA4 PLEKHG2 CSPG4 DAAM2 ASB2	6.51e-06	162	191	7	c7114e24cb5525abb9780ca3d35dbcc4eabd4b64
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A DUOX2 GRIA4 PLEKHG2 CSPG4 DAAM2 ASB2	6.51e-06	162	191	7	f1851a173d3bcca2981d934161ec85d1cc0af5a2
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PDE3A ZCCHC12 ZFP57 SVIL SNTB1 EPB41L2 TPBG	7.95e-06	167	191	7	1c1b4722c6c0eff85a9b32ca7b4e281caebf63b0
ToppCell	Fetal_29-31_weeks-Epithelial-basal_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CDH26 ITGB4 FAT2 SERPINB10 PER2 TP63 AVPI1	8.26e-06	168	191	7	6521bead9789d626b86cbd08692c621c5a5aef33
ToppCell	Fetal_29-31_weeks-Epithelial-basal_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CDH26 ITGB4 FAT2 SERPINB10 PER2 TP63 AVPI1	8.59e-06	169	191	7	c3ee781735a9288ce1822b230d39bb91c1415589
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDE3A PARD6G GRIA4 LRP1B CSPG4 DAAM2 SNTB1	8.93e-06	170	191	7	5570c0e825bca77613bf0ebde620cf744fa1cb84
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A PLEKHG2 HEPH DAAM2 GRIN3A EPB41L2	8.93e-06	170	191	7	876b84740e15399bfff2b9c7f0b80fd759bbdb3f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A PLEKHG2 HEPH DAAM2 GRIN3A EPB41L2	8.93e-06	170	191	7	1f8738acf439d893880db7e1fdc9b3615ca00c39
ToppCell	Control-Epithelial_cells-Airway_basal\|Control / group, cell type (main and fine annotations)	CDH26 TRIM2 CACHD1 ITGB4 FAT2 FBXL18 TP63	9.27e-06	171	191	7	3965ced4be6db14265a90673502fceee425837ca
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CCNO ITGB4 NCCRP1 FAT2 SERPINB10 TMEM184A TP63	1.04e-05	174	191	7	9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c
ToppCell	10x5'-GI_small-bowel-Mast-Mast_cells\|GI_small-bowel / Manually curated celltypes from each tissue	PDE3A NTRK1 PAQR5 LRP1B SEMA4A TSSK4 TNS1	1.04e-05	174	191	7	05525bf0a2bde2be4f7c147b17a24530ce8819e0
ToppCell	10x5'-GI_small-bowel-Mast\|GI_small-bowel / Manually curated celltypes from each tissue	PDE3A NTRK1 PAQR5 LRP1B SEMA4A TSSK4 TNS1	1.04e-05	174	191	7	e94c980b25edfd0e8598c416828801fcc00e8ead
ToppCell	Adult-Endothelial-endothelial_cell_of_artery-D175\|Adult / Lineage, Cell type, age group and donor	PDE3A NPDC1 LRP1B HEPH PIK3C2B PCDH11X DCHS1	1.08e-05	175	191	7	0a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-8\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	NEIL1 PEG10 NEB CD180 MYO15A BANK1 EPB41L2	1.16e-05	177	191	7	066e7500e7bdde88a7914f50a4661d8adf6db925
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CDH26 TRIM2 EPS8L1 BCL6 PER2 TMEM184A USP54	1.25e-05	179	191	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE3A SLC6A17 RASL12 BCL6 CSPG4 DAAM2 TNS1	1.25e-05	179	191	7	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	Epithelial-basal_cell\|World / Lineage, Cell type, age group and donor	CDH26 CCNO CACHD1 ITGB4 FAT2 SERPINB10 TP63	1.25e-05	179	191	7	d9be6647ec7b22747dc00dce4ea307b6af412dfa
ToppCell	droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ACACB ITGB4 PIK3C2B AVPI1 SNTB1 TPBG CREB3L2	1.34e-05	181	191	7	136b0c60680068838d184d32aa99d7bea8718dbc
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ACACB RASL12 CACHD1 ITGB4 HEPH DAAM2 SNTB1	1.34e-05	181	191	7	0c3f469bed108994ed696230e3c30343f7a301d3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 ABCA8 DPEP3 DAAM2 EPB41L2	1.39e-05	182	191	7	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	B_cells-Naive_B_cells_\|World / Immune cells in Kidney/Urine in Lupus Nephritis	NEIL1 WDFY4 PIK3C2B KCNG1 CD180 BANK1 TREML2	1.39e-05	182	191	7	63c3b63315276b66667d49fab09661ac320e7a36
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 ABCA8 DPEP3 DAAM2 EPB41L2	1.39e-05	182	191	7	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	3'_v3-bone_marrow-Myeloid_Dendritic-DC2\|bone_marrow / Manually curated celltypes from each tissue	DTNA LRP1B ZNF503 SEMA4A CD180 EPB41L2 CACNA2D3	1.44e-05	183	191	7	f482e4fe011fa450a475034b1e25587233855bdb
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A LAMC3 RASL12 PLEKHG2 DAAM2 TNS1 PDZRN3	1.44e-05	183	191	7	667717366cb181b8a04a347e64f0f5a4dfc6ee7f
ToppCell	Adult-Epithelial-basal_cell\|Adult / Lineage, Cell type, age group and donor	CDH26 CACHD1 C2orf78 ITGB4 FAT2 TP63 TPBG	1.44e-05	183	191	7	00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MIER2 RAMP2 TENT4B XPNPEP2 EPN2 FAM124A EPB41L2	1.44e-05	183	191	7	3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A17 NEB LRP1B PCDH11X PCDH15 ROS1 MYO15A	1.49e-05	184	191	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A17 NEB LRP1B PCDH11X PCDH15 ROS1 MYO15A	1.49e-05	184	191	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A17 NEB LRP1B PCDH11X PCDH15 ROS1 MYO15A	1.49e-05	184	191	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A DUOX2 LAMC3 RASL12 CSPG4 DAAM2 EPB41L2	1.55e-05	185	191	7	7092436b4db90289516ed130ade596e3021cffaf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A DUOX2 LAMC3 RASL12 CSPG4 DAAM2 EPB41L2	1.55e-05	185	191	7	a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PDE3A DTNA SVIL PCDH11X PCDH15 CACNA2D3 TPBG	1.55e-05	185	191	7	7dcdc009c5681ee05dd18968f7e85c3403fe34af
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-4\|TCGA-Bladder / Sample_Type by Project: Shred V9	ITGA11 CHRDL2 RASL12 HEPH FNDC1 TNS1 PDZRN3	1.55e-05	185	191	7	e1f3f0e974eb3fe1c05018beb9e124c7fb0cbe50
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE3A LAMC3 RASL12 CSPG4 DAAM2 TNS1 EPB41L2	1.60e-05	186	191	7	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PDE3A DTNA SVIL PCDH11X PCDH15 CACNA2D3 TPBG	1.66e-05	187	191	7	5258674d0346e5c51a4b965efcdc1790c970845d
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	AKNA STK4 NPHP3 ENTPD1 MYO1F MAPKBP1 EPB41L2	1.66e-05	187	191	7	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PRLHR ZCCHC12 BCL6 RGS12 FNDC1 PCDH15 GRIN3A	1.71e-05	188	191	7	433a25fe52914e07e7ba695881f9bcca2d9467ff
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	PDE3A LAMC3 RASL12 CSPG4 DAAM2 TNS1 EPB41L2	1.71e-05	188	191	7	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB SLC6A17 PAQR5 NCCRP1 C1QTNF4 CDH16 TPBG	1.71e-05	188	191	7	14e120b20e76baa07b6510a94f0c2dcdfdd52357
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Monocytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AKNA WDFY4 PRAM1 MYO1F CD180 BANK1 CACNA2D3	1.77e-05	189	191	7	a010f3e4da6e9bb23b0b9a7f82ad5cee4e607ecd
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	CDH26 TRIM2 CCNO CACHD1 ITGB4 FAT2 TP63	1.77e-05	189	191	7	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	CTRL-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	BMP2K WDFY4 SNX25 ENTPD1 CD180 MBD4 BANK1	1.77e-05	189	191	7	14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCDHAC1 PARD6G XPNPEP2 RGS12 FNDC1 RASA4 VPS35	1.77e-05	189	191	7	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACACB SLC6A17 PAQR5 NCCRP1 C1QTNF4 CDH16 TPBG	1.77e-05	189	191	7	443359d90fafae0c1de6bdcce9e8c95df6ea4de8
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ITGA11 PDE3A GRIA4 LAMC3 RASL12 TMEM266 PDZRN3	1.77e-05	189	191	7	9c2492c38f27e4c699b40680652e4c64911cce52
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A RAMP2 ITGB4 PIK3C2B ENTPD1 PCDH11X ITPRIP	1.83e-05	190	191	7	bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A CES1 ABCA8 DAAM2 GRIN3A EPB41L2	1.83e-05	190	191	7	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DTNA LRP1B DUSP26 FNDC1 SVIL ENTPD1 ASB2	1.83e-05	190	191	7	938d1f66094b1c94606e0d40213a39e5112f3322
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ITGA11 PDE3A GRIA4 LAMC3 RASL12 CSPG4 TMEM266	1.83e-05	190	191	7	10125091ad648163777b02e9f0d5e8d7f17d44a5
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|RV / Chamber and Cluster_Paper	PDE3A ACACB DTNA SVIL CPEB4 PDZRN3 CACNA2D3	1.83e-05	190	191	7	fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMC3 RASL12 CSPG4 TMEM266 DAAM2 TNS1 EPB41L2	1.90e-05	191	191	7	1626b23a57429f835fddc052e3c57f63a4e5b8bb
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 ABCA8 FNDC1 DAAM2 EPB41L2	1.90e-05	191	191	7	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 ABCA8 HEPH FNDC1 EPB41L2	1.90e-05	191	191	7	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 ABCA8 FNDC1 DAAM2 EPB41L2	1.90e-05	191	191	7	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMC3 RASL12 CSPG4 TMEM266 DAAM2 TNS1 EPB41L2	1.90e-05	191	191	7	716dfa7fccbd62b5f574792e68a26dc6c45511dc
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 ABCA8 HEPH FNDC1 EPB41L2	1.90e-05	191	191	7	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRIM2 PEG10 LAMC3 RASL12 ABCA8 FNDC1 TPBG	2.03e-05	193	191	7	6ef9007c9d18fb775d08fb20cdf954a28d54d7eb
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRIM2 PEG10 LAMC3 RASL12 ABCA8 FNDC1 TPBG	2.03e-05	193	191	7	e4ea7ce011a80b81b841c907719aa532bed39d2e
ToppCell	10x5'v1-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TRIM2 PEG10 LAMC3 RASL12 ABCA8 FNDC1 TPBG	2.03e-05	193	191	7	cf2461af78f65616ce40d552ee9452295e3895ed
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 ABCA8 HEPH DAAM2 EPB41L2	2.10e-05	194	191	7	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	PBMC-Control-Myeloid-cDC-cDC-cDC_3\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DTNA WDFY4 ZNF503 ENTPD1 SEMA4A EPB41L2 CACNA2D3	2.10e-05	194	191	7	2210f0755882d8f04edb4c109fb17c3f9149f6f7
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ITGA11 PDE3A LAMC3 RASL12 FNDC1 CSPG4 PDZRN3	2.10e-05	194	191	7	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A DTNA RASL12 CSPG4 ENTPD1 DAAM2 ASB2	2.10e-05	194	191	7	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE3A DTNA RASL12 CSPG4 ENTPD1 DAAM2 ASB2	2.10e-05	194	191	7	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA11 PDE3A LAMC3 ABCA8 HEPH DAAM2 EPB41L2	2.10e-05	194	191	7	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	PDE3A LAMC3 RASL12 CSPG4 DAAM2 ASB2 PDZRN3	2.10e-05	194	191	7	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; PC3; HT_HG-U133A	TRIM2 HDAC4 ACACB HTRA2 ZNF236 OGDH ITGB4 MKS1 BAP1 FBXL18 NPAS2	6.08e-07	191	189	11	4289_DN
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A	EMC1 DTNA MED14 CCNO NEB EMSY EPN2 XYLT2 FBXL18 KCNG1 MAPKBP1	8.26e-07	197	189	11	5436_DN
Drug	Thonzonium bromide [553-08-2]; Down 200; 6.8uM; MCF7; HT_HG-U133A	EMC1 BMP2K MED14 EPS8L1 NEB TRIM3 CES2 BLVRA STK4 BTD HERC6	8.68e-07	198	189	11	5678_DN
Drug	Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A	DTNA RGS12 EPN2 XYLT2 PIK3C2B KCNG1 SUPT6H SERGEF MYO1F EPB41L2	6.16e-06	197	189	10	5415_DN
Drug	Ifenprodil tartrate [23210-58-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A	ACTR8 DTNA NEB MKS1 STK4 ARSB FBXL18 MOGS BTD SMAD5	6.16e-06	197	189	10	5463_DN
Drug	Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A	IPO5 ACTR8 EMC1 MED14 EPS8L1 NEB RGS12 BTD SVIL SEMA4A	6.44e-06	198	189	10	4808_DN
Drug	tump	ACACA KCNG1 TP63	3.06e-05	8	189	3	CID003080705
Drug	Danazol [17230-88-5]; Down 200; 11.8uM; HL60; HG-U133A	EMC1 ACACA HTRA2 DTNA OGDH TRMT2A PIK3C2B NFRKB MAPKBP1	3.26e-05	191	189	9	2038_DN
Drug	Fillalbin [4540-25-4]; Up 200; 13.8uM; MCF7; HT_HG-U133A	TRIM2 EMC1 SYNC ZNF236 TRMT2A PER2 CLCN7 BTD SEMA4A	3.39e-05	192	189	9	2813_UP
Drug	Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A	TM7SF3 CCNO EPS8L1 ITGB4 EPN2 XYLT2 STK4 TRMT2A SMAD5	3.68e-05	194	189	9	7214_DN
Drug	Albendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A	MRE11 EMC1 HTRA2 PER2 PIK3C2B NFRKB SEMA4A MAPKBP1 GCN1	3.68e-05	194	189	9	1547_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A	OGDH ITGB4 TRIM3 BAP1 FBXL18 MOGS SUPT6H SVIL NFRKB	3.68e-05	194	189	9	4284_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	EMC1 HDAC4 BMP2K EPS8L1 OGDH ITGB4 TRMT2A PDZRN3 SMAD5	3.83e-05	195	189	9	1639_DN
Drug	Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A	HDAC4 DTNA EPS8L1 CES2 PIK3C2B SVIL SEMA4A MAPKBP1 EPB41L2	3.83e-05	195	189	9	4784_DN
Drug	Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A	ACTR8 BMP2K MED14 CCNO NEB TRIM3 THOP1 BTD HERC6	3.99e-05	196	189	9	5676_DN
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A	TRIM2 DTNA NEB OGDH EMSY EPN2 HINFP ARSB SEMA4A	3.99e-05	196	189	9	1474_DN
Drug	Papaverine hydrochloride [61-25-6]; Down 200; 10.6uM; MCF7; HT_HG-U133A	ACTR8 TRIM2 EPS8L1 EPN2 FBXL18 PER2 KCNG1 BTD MAPKBP1	3.99e-05	196	189	9	6245_DN
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	ACTR8 BMP2K MED14 CCNO SYNC EPS8L1 C2CD3 NFRKB SEMA4A	3.99e-05	196	189	9	7200_UP
Drug	Buspirone hydrochloride [33386-08-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	TRIM2 BMP2K NEB RGS12 STK4 CLCN7 KCNG1 SUPT6H BTD	3.99e-05	196	189	9	5343_UP
Drug	Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A	EMC1 SYNC ITGB4 RGS12 UTS2 SUPT6H ENTPD1 MYO1F TNS1	4.15e-05	197	189	9	6249_UP
Drug	Meprylcaine hydrochloride [956-03-6]; Down 200; 14.8uM; MCF7; HT_HG-U133A	IPO5 TRIM2 BMP2K DTNA ZNF212 EPS8L1 OGDH EPN2 SEMA4A	4.15e-05	197	189	9	3544_DN
Drug	celecoxib; Down 200; 10uM; PC3; HG-U133A	EMC1 EPS8L1 XYLT2 LLGL1 FBXL18 TRMT2A ENTPD1 LGALS13 TNS1	4.15e-05	197	189	9	482_DN
Drug	Demecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A	BMP2K DTNA CCNO EPS8L1 ITGB4 RGS12 EPN2 CLCN7 HERC6	4.15e-05	197	189	9	2773_DN
Drug	Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A	TRIM2 EMC1 CCNO LAMC3 CES2 ARSB KCNG1 SUPT6H SVIL	4.15e-05	197	189	9	5353_UP
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; HL60; HG-U133A	EMC1 MED14 OGDH HINFP TRMT2A UBR5 MAPKBP1 MBD4 SMAD5	4.15e-05	197	189	9	1394_UP
Drug	Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A	ACACB EPS8L1 ITGB4 CES2 STK4 LLGL1 TRMT2A CLCN7 SVIL	4.31e-05	198	189	9	5829_UP
Drug	fluphenazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A	TRIM2 PEG10 EPS8L1 RGS12 EPN2 UTS2 CD180 TREML2 SMAD5	4.31e-05	198	189	9	6196_UP
Drug	L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A	EPS8L1 ZNF236 RGS12 CES2 BAP1 TRMT2A KCNG1 MYO1F EPB41L2	4.31e-05	198	189	9	5475_DN
Drug	Clioquinol [130-26-7]; Down 200; 13uM; MCF7; HT_HG-U133A	TM7SF3 EPS8L1 ZNF236 OGDH TRIM3 BTD MYO1F PDZRN3 EPB41L2	4.31e-05	198	189	9	5258_DN
Drug	Gabapentin [60142-96-3]; Down 200; 23.4uM; MCF7; HT_HG-U133A	TRIM2 DTNA EPS8L1 BLVRA STK4 ARSB BTD NFRKB SEMA4A	4.31e-05	198	189	9	3472_DN
Drug	aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A	LAMB4 RAMP2 ACACB PEG10 GRIA4 RGS12 TRIM3 TP63 LTK	4.49e-05	199	189	9	6164_UP
Drug	Sulfadoxine [2447-57-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A	IPO5 TM7SF3 ITGB4 MKS1 FBXL18 KCNG1 SUPT6H BTD EPB41L2	4.49e-05	199	189	9	7205_DN
Drug	Azathioprine [446-86-6]; Down 200; 14.4uM; PC3; HG-U133A	IPO5 ACTR8 TRIM2 DTNA CES2 BAP1 KCNG1 SUPT6H NPAS2	4.49e-05	199	189	9	1945_DN
Drug	1-phenyl-1,2-propanedione	CES1 OGDH CES2	6.47e-05	10	189	3	CID000011363
Drug	5-iodoisatin	CES1 CES2	6.85e-05	2	189	2	CID000088695
Drug	5-chloro-7-methylisatin	CES1 CES2	6.85e-05	2	189	2	CID000366710
Drug	I08-742	CES1 CES2	6.85e-05	2	189	2	CID002786143
Drug	3,3'-dimethoxybenzil	CES1 CES2	6.85e-05	2	189	2	CID000123493
Drug	tolserine	CES1 CES2	6.85e-05	2	189	2	ctd:C412047
Drug	NSC-379518	CES1 CES2	6.85e-05	2	189	2	CID000137905
Drug	aceanthrenequinone	CES1 CES2	6.85e-05	2	189	2	CID000316765
Drug	7-trifluoromethylisatin	CES1 CES2	6.85e-05	2	189	2	CID000604575
Drug	5-chloroisatin	CES1 CES2	6.85e-05	2	189	2	CID000087203
Drug	4-Chlorobenzil	CES1 CES2	6.85e-05	2	189	2	CID000089801
Drug	4,5-dichloro-1H-indole-2,3-dione	CES1 CES2	6.85e-05	2	189	2	CID005139980
Drug	p-methylbenzil	CES1 CES2	6.85e-05	2	189	2	CID000075511
Drug	AC1Q27R1	CES1 CES2	6.85e-05	2	189	2	CID000087502
Drug	AC1M2MWF	CES1 CES2	6.85e-05	2	189	2	CID002147394
Drug	d18-75	CES1 CES2	6.85e-05	2	189	2	CID000076996
Drug	NSC 408976	CES1 CES2	6.85e-05	2	189	2	CID000101375
Drug	2,2'-Dichlorobenzil	CES1 CES2	6.85e-05	2	189	2	CID000089076
Drug	6-chloro-7-methyl-1H-indole-2,3-dione	CES1 CES2	6.85e-05	2	189	2	CID004513067
Drug	5,7-dichloroisatin	CES1 CES2	6.85e-05	2	189	2	CID000080771
Drug	p-methoxybenzil	CES1 CES2	6.85e-05	2	189	2	CID000031494
Drug	AC1N9FPX	CES1 CES2	6.85e-05	2	189	2	CID004384851
Drug	4-nitrobenzil	CES1 CES2	6.85e-05	2	189	2	CID000283893
Drug	chloroisatin	CES1 CES2	6.85e-05	2	189	2	CID000137777
Drug	4-chloro-7-methyl-1h-indole-2,3-dione	CES1 CES2	6.85e-05	2	189	2	CID001810509
Drug	acetaldophosphamide	CES1 CES2	6.85e-05	2	189	2	CID000163905
Drug	4,4'-Difluorobenzil	CES1 CES2	6.85e-05	2	189	2	CID000123072
Drug	4,4'-Dichlorobenzil	CES1 CES2	6.85e-05	2	189	2	CID000018946
Drug	1-laurylisatin	CES1 CES2	6.85e-05	2	189	2	CID001897797
Drug	1-cetylisatin	CES1 CES2	6.85e-05	2	189	2	CID003772674
Drug	AC1M5V1J	CES1 CES2	6.85e-05	2	189	2	CID002385967
Drug	DNC005462	CES1 CES2	6.85e-05	2	189	2	CID011437501
Drug	2-nitrophenylacetic acid	CES1 CES2	6.85e-05	2	189	2	ctd:C119971
Drug	DNC005463	CES1 CES2	6.85e-05	2	189	2	CID011392969
Drug	AC1MS20N	CES1 CES2	6.85e-05	2	189	2	CID003527426
Drug	9-amino-6-chloro-2-methoxyacridine	CES1 CES2	6.85e-05	2	189	2	ctd:C010847
Drug	1,2-bis(4-nitrophenyl)ethane-1,2-dione	CES1 CES2	6.85e-05	2	189	2	CID001812008
Drug	4-amino-2,6-dimethylphenol	CES1 CES2	6.85e-05	2	189	2	CID000082667
Drug	2-chloro-3',4'-dimeth-oxy-benzil	CES1 CES2	6.85e-05	2	189	2	CID000092036
Drug	4,7-dichloroisatin	CES1 CES2	6.85e-05	2	189	2	CID002734793
Drug	4,6-dichloro-1h-indole-2,3-dione	CES1 CES2	6.85e-05	2	189	2	CID000251908
Drug	AC1LWPKX	CES1 CES2	6.85e-05	2	189	2	CID001755771
Drug	AC1Q2DS8	CES1 CES2	6.85e-05	2	189	2	CID002427416
Drug	1,2-dicyclohexylethane-1,2-dione	CES1 CES2	6.85e-05	2	189	2	CID011806279
Drug	DP00565	CES1 CES2	6.85e-05	2	189	2	CID002777298
Drug	diethyl fluoromalonate	CES1 CES2	6.85e-05	2	189	2	CID000012702
Drug	anisil	CES1 CES2	6.85e-05	2	189	2	CID000071043
Drug	4-chloroisatin	CES1 CES2	6.85e-05	2	189	2	CID000096047
Drug	6-O-monoacetylmorphine	CES1 CES2	6.85e-05	2	189	2	ctd:C026979
Drug	NNMP	CES1 CES2	6.85e-05	2	189	2	CID000146767
Drug	aniracetam	CES1 CES2	6.85e-05	2	189	2	ctd:C036466
Drug	AC1Q24Z2	CES1 CES2	6.85e-05	2	189	2	CID004338240
Drug	1-benzyl-1h-indole-2,3-dione	CES1 CES2	6.85e-05	2	189	2	CID000264734
Drug	prolyl-beta-naphthylamide	CES1 CES2	6.85e-05	2	189	2	CID000167505
Drug	5-(Trifluoro-meth-oxy)isatin	CES1 CES2	6.85e-05	2	189	2	CID002732752
Drug	hostacain	CES1 CES2	6.85e-05	2	189	2	CID000022378
Drug	phenethylcymserine	CES1 CES2	6.85e-05	2	189	2	ctd:C576198
Drug	5,6-dichloro-1H-indole-2,3-dione	CES1 CES2	6.85e-05	2	189	2	CID011009341
Drug	4-nitrophenylacetic acid	CES1 CES2	6.85e-05	2	189	2	ctd:C118008
Drug	AC1MBV04	CES1 CES2	6.85e-05	2	189	2	CID002731732
Drug	AC1N4VNK	CES1 CES2	6.85e-05	2	189	2	CID004135273
Drug	5-hydroxy-5-methylhydantoin	NEIL1 CCNO UBR5	1.17e-04	12	189	3	CID003014609
Drug	fluazifop-butyl	ACACA CES1 CES2	1.51e-04	13	189	3	CID000050897
Drug	1-methyl-2-nitro-1-nitrosoguanidine	MRE11 DDR1 CHDH CCNO DUOX2 EPS8L1 CES2 MOGS MBD4	1.76e-04	238	189	9	CID000006261
Drug	resveratrol; Up 200; 50uM; PC3; HG-U133A	TRIM2 PNPLA4 BCL6 HINFP XYLT2 STK4 CLCN7 PIK3C2B	2.02e-04	191	189	8	662_UP
Drug	2-tridecanol	CES1 CES2	2.05e-04	3	189	2	CID000015449
Drug	indandione	CES1 CES2	2.05e-04	3	189	2	CID000123358
Disease	muscular dystrophy (implicated_via_orthology)	TRIM2 FKRP TRIM3 SNTB1	8.41e-06	21	186	4	DOID:9884 (implicated_via_orthology)
Disease	autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology)	TRIM2 TRIM3	1.18e-04	3	186	2	DOID:0110282 (implicated_via_orthology)
Disease	autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology)	TRIM2 TRIM3	1.18e-04	3	186	2	DOID:0110274 (implicated_via_orthology)
Disease	uveal melanoma (is_implicated_in)	BAP1 MBD4	2.35e-04	4	186	2	DOID:6039 (is_implicated_in)
Disease	neuroblastoma (implicated_via_orthology)	LLGL1 LTK	3.90e-04	5	186	2	DOID:769 (implicated_via_orthology)
Disease	muscular disease (implicated_via_orthology)	ACACA ACACB	3.90e-04	5	186	2	DOID:0080000 (implicated_via_orthology)
Disease	xaa‐pro aminopeptidase 2 measurement	XPNPEP2 PIGV	3.90e-04	5	186	2	EFO_0010625
Disease	lipoprotein measurement	CES1 GCKR ABCA8 CES2 LLGL1	5.47e-04	105	186	5	EFO_0004732
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	PDE3A CES1 SPG11 GCKR ABCA8 RGS12 CES2	5.88e-04	225	186	7	EFO_0008317, EFO_0020947
Disease	mean platelet volume	HAUS6 PCDHGB3 DOCK11 TM7SF3 UNC13D GCKR RGS12 STK4 FBXL18 BTD SVIL CPEB4 MAP3K11 ITPRIP BANK1 SMAD5	7.78e-04	1020	186	16	EFO_0004584
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	KIF27 ACACB CES1 GCKR ABCA8 RGS12 CES2	9.23e-04	243	186	7	EFO_0004612, EFO_0020944
Disease	neutrophil measurement	TM7SF3 BCL6 FAT2 ARSB UTS2 SSH2	9.31e-04	177	186	6	EFO_0803548
Disease	apolipoprotein A 1 measurement	PDE3A TRIM2 ACACB CES1 AKNA UNC13D SPG11 GCKR ABCA8 CES2 TYRO3 BANK1 SNTB1 CDH16	1.02e-03	848	186	14	EFO_0004614
Disease	serum albumin measurement	EXOSC10 TRIM2 GCKR ABCA8 RGS12 HINFP PHKG2 LLGL1 CPEB4 ASB2 BANK1	1.41e-03	592	186	11	EFO_0004535
Disease	Schizophrenia	IPO5 DDR1 HDAC4 NTRK1 GRIA4 RGS12 CFAP65 CYFIP1 TRMT2A VPS35 DAAM2 GRIN3A SMAD5 NPAS2	1.50e-03	883	186	14	C0036341
Disease	Meckel-Gruber syndrome	MKS1 NPHP3	1.72e-03	10	186	2	cv:C0265215
Disease	Erectile dysfunction	SHBG GRIN3A	1.72e-03	10	186	2	C0242350
Disease	Cocaine Dependence	HDAC4 CES1 CES2 PER2 SMAD5	1.92e-03	139	186	5	C0600427
Disease	Inherited neuropathies	MRE11 NTRK1 SPG11	2.05e-03	40	186	3	C0598589
Disease	N-acetylphenylalanine measurement	ACY3 C2orf78	2.09e-03	11	186	2	EFO_0800019
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	CES1 SPG11 GCKR OGDH CES2	2.24e-03	144	186	5	EFO_0004611, EFO_0020943
Disease	N-acetyl-2-aminooctanoate measurement	BTD TMEM266	2.50e-03	12	186	2	EFO_0800567
Disease	Herpes Zoster, response to tofacitinib	ZBP1 CACNA2D3	2.50e-03	12	186	2	EFO_0006510, EFO_0600024
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ACACB CES1 SPG11 GCKR ABCA8 CES2 BANK1	2.57e-03	291	186	7	EFO_0008317, EFO_0020946
Disease	hearing impairment	ARSB BTD PCDH15 MYO15A	3.48e-03	98	186	4	C1384666
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	PDE3A CES1 GCKR ABCA8 RGS12 CES2 MAPKBP1	3.77e-03	312	186	7	EFO_0004612, EFO_0010351
Disease	glucose homeostasis measurement, glucose effectiveness measurement	GCKR BCL6	3.93e-03	15	186	2	EFO_0006833, EFO_0006896
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	PDE3A CES1 GCKR ABCA8 CES2 LLGL1 MAPKBP1	3.98e-03	315	186	7	EFO_0004612, EFO_0008591
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	PDE3A CES1 GCKR ABCA8 RGS12 CES2 MAPKBP1	3.98e-03	315	186	7	EFO_0004574, EFO_0004612
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	SPG11 GCKR LLGL1 BANK1	4.16e-03	103	186	4	EFO_0008595, EFO_0020944
Disease	pro-hydroxy-pro measurement	XPNPEP2 SERPINB10	4.47e-03	16	186	2	EFO_0021132
Disease	Inborn Errors of Metabolism	CES1 SERPINA7	5.05e-03	17	186	2	C0025521
Disease	cortical surface area measurement	ITGA11 PDE3A TRIM2 CHRDL2 LAMC3 SYNC CACHD1 BLVRA CPEB4 USP35 SSH2 CD180 TNS1 PDZRN3 BANK1 SNTB1 SMAD5	5.15e-03	1345	186	17	EFO_0010736
Disease	uric acid measurement	NTRK1 GCKR XPNPEP2 HSF5 CPEB4 TMEM266 MAP3K11 EPB41L2 CACNA2D3 NPAS2	5.54e-03	610	186	10	EFO_0004761
Disease	Meckel syndrome type 1	MKS1 NPHP3	5.66e-03	18	186	2	C3714506
Disease	prostate carcinoma, type 2 diabetes mellitus	HAUS6 ZNF236 EMSY	6.18e-03	59	186	3	EFO_0001663, MONDO_0005148
Disease	free cholesterol to total lipids in very large VLDL percentage	GCKR RGS12 MAP3K11	6.18e-03	59	186	3	EFO_0022289

Protein segments in the cluster

Peptide	Gene	Start	Entry
PVANAFQLERPHFTL	BANK1	516	Q8NDB2
TPEELQAERNFHTVP	CES1	331	P23141
GTVHPQLQDRDFQPL	ACY3	241	Q96HD9
SVPSPQRSEHDVLFQ	CSPG4	1736	Q6UVK1
LPFLTLDQPQARHVS	C2orf78	721	A6NCI8
FHPREALARQPQVTA	CCNO	116	P22674
LQHGADPNRDVISPL	ASB2	431	Q96Q27
QDHEFQIRHPDSPAL	ACTR8	361	Q9H981
VSVHEDQLQAPAERP	CARMIL2	1361	Q6F5E8
ESEQRPPFSQLHRFL	DDR1	891	Q08345
RILEPHSALANPQSA	AVPI1	96	Q5T686
PRHQPLAFDTEFVNI	C1QTNF4	196	Q9BXJ3
EPLVANDILNHPNFV	CACHD1	871	Q5VU97
PLAQPLELNQHSRFI	ACACA	6	Q13085
TPIVQRLPAFLDNHN	BAP1	351	Q92560
DLAFTRLHINAPQSP	CD180	426	Q99467
PQHRFPAAGLEQEEF	BMP2K	881	Q9NSY1
PASPRELLLDHQAVF	DISP2	1211	A7MBM2
PDIQFHFLPSQVIDH	CHDH	396	Q8NE62
FPFTHVRLLDQQNPD	CRK	286	P46108
ERFPGAQHENVPFIA	RASA4	451	O43374
LFISEERALPHQAPL	RASL12	196	Q9NYN1
FPNPLAERIIFETHQ	RAMP2	111	O60895
QQLPEHLERCDFAPA	PDZRN3	96	Q9UPQ7
ERFPGAQHENVPFIA	RASA4B	451	C9J798
HNAFALLVRPPTEQA	ECT2	751	Q9H8V3
IINHPLLFPRENATV	ITPRIP	16	Q8IWB1
PDSPSNLLRFIQEVH	PTPN23	1361	Q9H3S7
LPRLFSIDQIPQVFH	PAQR5	6	Q9NXK6
AHLEEALSFQLPSRP	LLGL1	111	Q15334
QPSPDFSHDRQLRLL	NPAS2	661	Q99743
FHFLELNPRLQVEHP	ACACB	576	O00763
SHALPAEQRDFLPLE	TENT4B	11	Q8NDF8
DLLHAAPFQNILPRV	CYFIP1	1021	Q7L576
DIPEINLRDNHPLQF	DAAM2	21	Q86T65
VRVADINDHAPAFPQ	DCHS1	131	Q96JQ0
INDHAPAFPQARAAL	DCHS1	136	Q96JQ0
PAFPQARAALQVPEH	DCHS1	141	Q96JQ0
DVHARLQALAQAPPV	NTRK1	776	P04629
PPRLQSLFEEHLQGQ	NOP9	341	Q86U38
AHPIANFPLQRLLDA	NOP9	361	Q86U38
LRLDHQFSLPVAEPA	HDAC4	51	P56524
LVFRDVAPQAPVHFL	HINT2	76	Q9BX68
PIENLVNPRALDFHA	LRP1B	551	Q9NZR2
QREHLQQFLPQFPED	NFRKB	66	Q6P4R8
SVLEALQQHRPSPEL	NEIL1	196	Q96FI4
ENPPHLFAVANLAFA	MYO15A	1286	Q9UKN7
QSEELQPLSQRHPFL	EPN2	216	O95208
RLHNPSAVNAPFRIE	CFAP65	381	Q6ZU64
LQTHPEAQRAIEAAP	FLYWCH2	81	Q96CP2
EPFFNSLQEVHPQVR	DUOX2	1496	Q9NRD8
PAQPSEAHARQLLLE	NCCRP1	61	Q6ZVX7
FPVVEHADDTQPARL	CLCN7	661	P51798
RQASTLIDRPAPHFE	EPB41L2	526	O43491
ASAPDPHQQLAFLEI	EID2B	76	Q96D98
AQDPFLVSIHIIADP	FAM124A	41	Q86V42
QHEPELRPSFASILE	LTK	761	P29376
PFNLVPHVDNIETAN	GRIA4	61	P48058
PRAIQEIFQSISEHP	KIF27	111	Q86VH2
FTVPAVPVDLQHQFA	PER2	876	O15055
LHVEDVNDNAPRFFP	FAT2	3101	Q9NYQ8
EQILPQSAEAAPREH	PDE3A	256	Q14432
ESILPPSAHELAQNR	PNPLA4	96	P41247
RHPQELLASADFQPV	CES2	321	O00748
RQLFRDNHLIPAETP	HERC6	601	Q8IVU3
NNPLDLPERIAAHSF	EEF1AKMT1	121	Q8WVE0
IIRSPQDDASSPHLQ	PEG10	336	Q86TG7
QPIDFVPNALRHAVD	GLT8D1	46	Q68CQ7
LFQFFVPDALNDRHP	GCN1	1256	Q92616
DASFHPAFLPQRQAI	KCNG1	21	Q9UIX4
RPVVQINASLHFEPS	ITGA11	636	Q9UKX5
PSDPQAELQFHLVVA	PCDHGB3	681	Q9Y5G1
DHEIPFRLRPVFSNQ	PCDH11X	401	Q9BZA7
PSPDNLRRFALEHEA	CHRDL2	346	Q6WN34
QVASNEILRDPCFHP	ENTPD1	271	P49961
VNFVLLFLQDPHPRV	IPO5	401	O00410
HQEVPSEPGRLAFNV	ITGB4	1216	P16144
PEARLTAEQALQHPF	PHKG2	276	P15735
APRVLQNFHPDEAES	PARD6G	281	Q9BYG4
LEFARSLPDIPAHLN	MED14	781	O60244
DARSPDIALHVASQP	MEI1	1136	Q5TIA1
EFLVQRAVHANPPTL	MOGS	501	Q13724
HEFPRESQNPLHLQL	GRIN3A	226	Q8TCU5
PNFHQPDSVILQIDF	PIK3C2B	771	O00750
AIHFPQPLSDDIRAA	GCKR	541	Q14397
VRNPLFDHAALSAPL	NPDC1	301	Q9NQX5
LIQDINDHSPIFPER	PCDHB4	121	Q9Y5E5
RIHVLDTNDNSPLFP	PCDHAC1	111	Q9H158
PIHSFINDPQLQVDF	LGALS13	26	Q9UHV8
RVVNAPIFHVNSDDP	OGDH	466	Q02218
TERNIFENFAHPPNI	PCDH15	1726	Q96QU1
REFNEGQIAPPSHLI	TP63	251	Q9H3D4
LDVPPALADFIHQQR	EXOSC10	231	Q01780
ELQLREPSFPDVQHG	HTRA2	376	O43464
APLPFDRVLVNEQGH	C1QTNF5	121	Q9BXJ0
LDQVHPPINEDSLRA	C2CD3	346	Q4AC94
ISADFHVDLNPPSVR	DOCK11	411	Q5JSL3
EFILAPNDHFNNLPV	CACNA2D3	151	Q8IZS8
HRPSLPASLNDNDLV	FNDC1	631	Q4ZHG4
FQALPPELREQTVHE	C1orf112	536	Q9NSG2
HPAFARQAAQEPSAV	FOXJ1	221	Q92949
NPCLEPHRFNDTEVL	BTD	141	P43251
LEDFRLAQQHLPPLE	AKNA	56	Q7Z591
EIALHFEPPNAPLNR	BCL6	311	P41182
DLRNPHPSSAFLNLI	BLVRA	26	P53004
PRSPFNLVQETLFHD	MBD4	441	O95243
SLVPQERHEASLQAP	MAPKBP1	1201	O60336
SPRIELLHNIDPNFV	ARSB	386	P15848
VEPIDRESPHVNNSF	CDH26	451	Q8IXH8
PLLHRLANVENVFHP	DTNA	226	Q9Y4J8
LPESLPVLHNQREFS	HAUS6	621	Q7Z4H7
VNNIPFPVDFTIAIH	LAMB4	611	A4D0S4
LFPAPATHNIQDEIL	CPEB4	61	Q17RY0
EVAFPLLVSHRSQPQ	EMSY	846	Q7Z589
PNPVDASRAQFFLHL	EMC1	281	Q8N766
FPLVDGHNDLPQVLR	DPEP3	91	Q9H4B8
RQDVEFPEHFLQPLV	FKRP	436	Q9H9S5
EPERAQPDVHFFQGL	EPS8L1	126	Q8TE68
FQSRNVIPDIPDHFL	HINFP	116	Q9BQA5
ELDNPFQDPAVIQHR	SCAMP3	16	O14828
QDPHRRPDFASILQQ	MAP3K11	361	Q16584
SDLRFHILSQAPAQP	CDH16	161	O75309
ESRPDVDLPHFIISN	CREB3L2	466	Q70SY1
FQQLDESPAVPLSHR	MIER2	431	Q8N344
PPAENSHGERLFQLE	FREM3	391	P0C091
ADLPPNELHFQLTAL	FREM3	1221	P0C091
LEAPPSQRDGHFLQE	SYNC	306	Q9H7C4
FHNPHFRRDQPQLLV	HSF5	111	Q4G112
FQLSAPHEDARLTPE	UTS2	31	O95399
ALADPENRQLEIHSP	SNTB1	256	Q13884
NEAAFLPVPQKIEAH	SERGEF	246	Q9UGK8
PHAFFQVNTPAAEVL	TRMT2A	406	Q8IZ69
APQTERNIPFTHLDN	TREML2	126	Q5T2D2
VFNLLRDLDPHAIDP	PRLHR	296	P49683
APQPALFLVDNHHEV	SVIL	2041	O95425
ALDPDHPRVAQSLHQ	NPHP3	976	Q7Z494
AANARHEEQPRPFVL	SNX25	76	Q9H3E2
PQDIVQDAIHNFSPA	TMEM184A	356	Q6ZMB5
QDALPPDAHVLASQR	PNPLA5	101	Q7Z6Z6
DRTPQNLHAFLISVP	FBXL18	256	Q96ME1
PPQRQDVDHDFFLLF	HEPH	216	Q9BQS7
AGLHFQDRQPEDIPQ	PRAM1	486	Q96QH2
FNVIRHAVLLPADSP	SEMA4A	301	Q9H3S1
TQAEFNLRDIPQPHA	SHBG	231	P04278
ESFDLPEERQIAHLP	PTTG2	126	Q9NZH5
DIVLANHPDIFNPDN	MRE11	311	P49959
EDHALAPVRNTIQLP	PRORP	101	O15091
PTVQHPFLNVFELER	DUSP26	36	Q9BV47
VPRHNEFNPQHSLLV	SMAD5	141	Q99717
EPLHAEILRLFPQAA	ABCA8	1526	O94911
FPAHLLQDQEPLLRS	PIGV	416	Q9NUD9
RHETEQFPAEPLELA	SUPT6H	556	Q7KZ85
DHLRLAFENLPSVPT	SPG11	1401	Q96JI7
FQPEQPTHEIRLLEA	TSSK4	296	Q6SA08
LLQIERFPQAAPLAH	TEX13D	146	A0A0J9YY54
PPVLSQEFILQNHAD	TRAM1L1	11	Q8N609
LALSSPAERPQQHAA	ZBP1	81	Q9H171
DVNHAPVARSQEPIF	ZFP57	236	Q9NU63
SQAQLADDVLRAPHP	RGS12	786	O14924
PSEEFVRNNHVINTP	MKS1	186	Q9NXB0
NATVPAPRVLEFDHL	SSH2	951	Q76I76
PDEFHLQTLNPFLRA	VPS35	271	Q96QK1
FHRPQNEARSLLPSE	SPATA31D1	606	Q6ZQQ2
EVHIPLENLQQFPAF	RNF10	631	Q8N5U6
LEHSQRPAISPENFL	USP35	491	Q9P2H5
HLFAELDPNQPASAI	TNS1	1706	Q9HBL0
PENTFLHPIIQIDRS	SERPINA7	376	P05543
ARIPAPLLQAHAAAQ	TMEM102	376	Q8N9M5
PAPVQEHFFQLLEAL	WDFY4	441	Q6ZS81
EPDQRPTFHRIQDQL	ROS1	2201	P08922
TLRGNAPVEVHFLDP	RHPN2P1	426	A8MT19
FVHAVPPSDPLRQAN	ZNF503	56	Q96F45
PPVLSHEFVLQNHAD	TRAM1	11	Q15629
HVQERFSPNSLVALP	ZNF212	401	Q9UDV6
FVAPQDPLRGHVDQF	ZNF236	851	Q9UL36
NVLSRDLIPPHVNFS	SLC6A17	381	Q9H1V8
PEQRATATQLLQHPF	STK4	266	Q13043
NHIVPPEDERQNRSF	TPBG	181	Q13641
LQRLFFENHPASIPA	PLEKHG2	406	Q9H7P9
LQQHTEPLAARAPDT	XPNPEP2	641	O43895
LNELADQDFPLHPRE	TRIM2	281	Q9C040
TVQRNILDFPQHVSP	THOP1	76	P52888
QLTLEPRHEFPELAA	UNC13D	951	Q70J99
LSQADRPHQLFADAP	SF3B4	201	Q15427
IRIRVPSIEFNANHP	SERPINB10	361	P48595
LPPQEASIHAQDRDN	USP6	931	P35125
APASAPQNLHAIRTD	TYRO3	321	Q06418
NLPQPELAEEAAQRH	XYLT2	786	Q9H1B5
EREAALQAPHVLSQP	TMEM266	276	Q2M3C6
PQDEVLVIDSPHNSR	ZCCHC12	301	Q6PEW1
DHDLEPPRFAQLALE	UBR5	1316	O95071
LAAQAFPERPHENAQ	TRIM3	281	O75382
FPERPHENAQLELVL	TRIM3	286	O75382
NRPFPEEAILHDISS	TM7SF3	46	Q9NS93
VDNIEPSAFHRQGLP	USP54	961	Q70EL1
RFHLQETSEDVAPPL	LAMC3	606	Q9Y6N6
RARPPSEHNTEFLNV	MYO1F	996	O00160
IPADAPQFIQHRVNA	NEB	786	P20929